Zynerba shares surge after Main Line firm wins patent for its CBD gel to treat Autism Spectrum Disorders The Philadelphia Inquirer
Shares in Zynerba Pharmaceuticals, Inc., a Philadelphia-area biotech, surged Tuesday morning on news it had been granted a U.S. patent for a novel method to …